Serum lidocaine concentrations in children during bronchoscopy with topical anesthesia

Y. Amitai, E. Zylber-Katz, A. Avital, D. Zangen, N. Noviski

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

To evaluate the safety of topical lidocaine anesthesia in children undergoing bronchoscopy, we determined SLC in 15 children aged 3 months to 9.5 years during flexible fiberoptic bronchoscopy. A total lidocaine dose of 3.2 to 8.5 (mean±SEM = 5.7±0.5) mg/kg was administered to nose, larynx and bronchial tree over 9 to 45 (mean±SEM = 20±2.7) minutes. No complication occurred during the procedure. Peak SLC were 1-3.5 (mean±SEM = 2.5±0.2) μg/ml. The Vdβ was 1.79±0.19 L/kg, the t1/2β was 109±12 minutes, and the total body clearance 12.2±1.1 ml/min/kg. Peak SLC correlated well with the dose expressed as mg/kg (r=0.59, p<0.025), and even better when related to body surface area (r=0.63, p<0.01). Lidocaine doses up to 8.5 mg/kg proved safe and resulted in therapeutic SLC in our patients. Lidocaine dose up to 7 mg/kg appears to be safe provided that it does not exceed an upper limit of 175 mg/m2 and is gradually administered over a minimum of 15 minutes. Doses of 7-8.5 mg/kg appear to be safe when administered over longer periods.

Original languageEnglish
Pages (from-to)1370-1373
Number of pages4
JournalChest
Volume98
Issue number6
DOIs
StatePublished - Dec 1990
Externally publishedYes

Bibliographical note

Funding Information:
Supported by a grant from the Israeli Ministry of Health.

Funding

Supported by a grant from the Israeli Ministry of Health.

FundersFunder number
Ministry of Health, State of Israel

    Fingerprint

    Dive into the research topics of 'Serum lidocaine concentrations in children during bronchoscopy with topical anesthesia'. Together they form a unique fingerprint.

    Cite this